Importer of Controlled Substances; Notice of Application; Cambrex Charles City, Inc., 38085 [2012-15622]
Download as PDF
<![CDATA[
38085
Federal Register / Vol. 77, No. 123 / Tuesday, June 26, 2012 / Notices
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. DEA has investigated
Clinical Supplies Management, Inc., to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic class of controlled
substance listed.
Dated: June 18, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–15620 Filed 6–25–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application; Cambrex
Charles City, Inc.
Pursuant to Title 21 Code of Federal
Regulations 1301.34 (a), this is notice
that on May 4, 2011, Cambrex Charles
City, Inc., 1205 11th Street, Charles City,
Iowa 50616–3466, made application by
renewal to the Drug Enforcement
Administration (DEA) for registration as
an importer of the following basic
classes of controlled substances:
Drug
Schedule
rmajette on DSK2TPTVN1PROD with NOTICES
4–Anilino-N-phenethyl-4-piperidine (8333).
Phenylacetone (8501) ..................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
II
II
II
II
The company plans to import the
listed controlled substances for internal
use, and to manufacture bulk
intermediates for sale to its customers.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedules I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act [21 U.S.C. 952
(a)(2)(B)] may, in the circumstances set
VerDate Mar<15>2010
15:33 Jun 25, 2012
Jkt 226001
forth in 21 USC 958(i), file comments or
objections to the issuance of the
proposed registration and may, at the
same time, file a written request for a
hearing on such application pursuant to
21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than July 26, 2012.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745, all applicants for
registration to import a basic class of
any controlled substance in schedules I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: June 18, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–15622 Filed 6–25–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Stepan
Company
By Notice dated May 11, 2012, and
published in the Federal Register on
May 21, 2012, 77 FR 30025, Stepan
Company, Natural Products Department,
100 W. Hunter Avenue, Maywood, New
Jersey 07607, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Coca Leaves (9040) a
basic class of controlled substance in
schedule II.
The company plans to import the
listed controlled substance to
manufacture bulk controlled substance
for distribution to its customer.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
DEA has considered the factors in 21
U.S.C. 823(a) and 952(a) and determined
that the registration of Stepan Company
to import the basic class of controlled
substance is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. DEA has investigated
Stepan Company to ensure that the
company’s registration is consistent
with the public interest.
The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic class of controlled
substance listed.
Dated: June 18, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–15621 Filed 6–25–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Cayman Chemical Company
By Notice dated March 8, 2012, and
published in the Federal Register on
March 20, 2012, 77 FR 16263, Cayman
Chemical Company, 1180 East Ellsworth
Road, Ann Arbor, Michigan 48108,
made application to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
4-Methyl-N-methylcathinone
(1248).
Gamma
Hydroxybutyric
Acid
(2010).
Mescaline (7381) ..........................
N-Benzylpiperazine (7493) ...........
3,4-Methylenedioxyprovalerone
(7535).
3,4-Methylenedioxy-Nmethylcathinone (7540).
Schedule
I
I
I
I
I
I
The company plans to manufacture
the above listed controlled substances to
supply these materials to the research
and forensics community for drug
testing and analysis.
E:\FR\FM\26JNN1.SGM
26JNN1
]]>Agencies
[Federal Register Volume 77, Number 123 (Tuesday, June 26, 2012)]
[Notices]
[Page 38085]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-15622]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application; Cambrex
Charles City, Inc.
Pursuant to Title 21 Code of Federal Regulations 1301.34 (a), this
is notice that on May 4, 2011, Cambrex Charles City, Inc., 1205 11th
Street, Charles City, Iowa 50616-3466, made application by renewal to
the Drug Enforcement Administration (DEA) for registration as an
importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
4-Anilino-N-phenethyl-4-piperidine (8333).. II
Phenylacetone (8501)....................... II
Opium, raw (9600).......................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
internal use, and to manufacture bulk intermediates for sale to its
customers.
Comments and requests for hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417 (2007).
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances listed in schedules I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act [21 U.S.C. 952 (a)(2)(B)] may, in
the circumstances set forth in 21 USC 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR
1316.47.
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than July 26, 2012.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, 40 FR 43745, all applicants for
registration to import a basic class of any controlled substance in
schedules I or II are, and will continue to be, required to demonstrate
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, that the requirements for such
registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR
1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: June 18, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-15622 Filed 6-25-12; 8:45 am]
BILLING CODE 4410-09-P
